Inventor profile of:

Andreas MÜHLER

City:

Munich

Country:

Germany

Published Applications:

12

Last publication date:

2026-05-14

Top Assignees for applications by Andreas MÜHLER

The entities that hold a legal rights for patent applications filed by inventor MÜHLER Andreas:

Recent patent applications by MÜHLER Andreas

Andreas MÜHLER from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14
US20260130879A1
Human necessities

VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS

#2 | 2025-05-01
US20250136542A1
Chemistry; metallurgy

CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS

#3 | 2025-04-17
US20250120931A1
Human necessities

TREATMENT OF MULTIPLE SCHLEROSIS COMPRISING DHODH INHIBITORS

#4 | 2025-01-30
US20250032527A1
Human necessities

MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDS

#5 | 2024-10-10
US20240335405A1
Human necessities

VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS

#6 | 2024-06-06
US20240180858A1
Human necessities

Treatment of Multiple Sclerosis Comprising DHODH Inhibitors

#7 | 2024-03-28
US20240100005A1
Human necessities

Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases

#8 | 2023-02-16
US20230051911A1
Human necessities

Treatment of multiple sclerosis comprising DHODH inhibitors

#9 | 2022-10-27
US20220339132A1
Human necessities

Vidofludimus for use in the treatment or prevention of viral diseases

#10 | 2021-10-21
US20210322351A1
Human necessities

Vidofludimus for use in the treatment or prevention of viral diseases

#11 | 2021-01-21
US20210017125A1
Chemistry; metallurgy

Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents

#12 | 2020-11-19
US20200360324A1
Human necessities

Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases

InventorID:

2907828